1. Home
  2. LCII vs IBRX Comparison

LCII vs IBRX Comparison

Compare LCII & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCII
  • IBRX
  • Stock Information
  • Founded
  • LCII 1956
  • IBRX 2014
  • Country
  • LCII United States
  • IBRX United States
  • Employees
  • LCII N/A
  • IBRX N/A
  • Industry
  • LCII Auto Parts:O.E.M.
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LCII Consumer Discretionary
  • IBRX Health Care
  • Exchange
  • LCII Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • LCII 2.2B
  • IBRX 2.3B
  • IPO Year
  • LCII N/A
  • IBRX N/A
  • Fundamental
  • Price
  • LCII $100.29
  • IBRX $2.81
  • Analyst Decision
  • LCII Buy
  • IBRX Strong Buy
  • Analyst Count
  • LCII 4
  • IBRX 5
  • Target Price
  • LCII $104.33
  • IBRX $11.40
  • AVG Volume (30 Days)
  • LCII 384.7K
  • IBRX 7.2M
  • Earning Date
  • LCII 08-05-2025
  • IBRX 08-11-2025
  • Dividend Yield
  • LCII 4.55%
  • IBRX N/A
  • EPS Growth
  • LCII 66.37
  • IBRX N/A
  • EPS
  • LCII 6.10
  • IBRX N/A
  • Revenue
  • LCII $3,818,769,000.00
  • IBRX $31,222,000.00
  • Revenue This Year
  • LCII $7.21
  • IBRX $567.98
  • Revenue Next Year
  • LCII $5.06
  • IBRX $160.56
  • P/E Ratio
  • LCII $16.59
  • IBRX N/A
  • Revenue Growth
  • LCII 1.04
  • IBRX 10238.41
  • 52 Week Low
  • LCII $72.31
  • IBRX $1.83
  • 52 Week High
  • LCII $129.38
  • IBRX $7.48
  • Technical
  • Relative Strength Index (RSI)
  • LCII 66.38
  • IBRX 51.33
  • Support Level
  • LCII $95.47
  • IBRX $2.68
  • Resistance Level
  • LCII $102.72
  • IBRX $3.00
  • Average True Range (ATR)
  • LCII 2.99
  • IBRX 0.16
  • MACD
  • LCII 0.76
  • IBRX -0.00
  • Stochastic Oscillator
  • LCII 83.77
  • IBRX 62.00

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: